GPT and Alzheimer disease: By employing advanced bioinformatics techniques, including machine learning algorithms and weighted gene co-expression network analysis (WGCNA), we identified three hub genes—MAP4, GPT, and HIRIP3—that hold promise as diagnostic and prognostic biomarkers for AD.